Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | IGF1R | P08069 | 2/20 | 0.36 |
| ▸ | ELANE | P08246 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | NAMPT | P43490 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6174151 | 0.90 | NAMPT (0.35) | IGF1RELANELMNANAMPTPTGS1 | |
| SCHEMBL6173841 | 0.88 | LIPE (0.41) | METAP2ELANELMNA | |
| SCHEMBL6176687 | 0.87 | IGF1R (0.33) | IGF1RLMNA | |
| SCHEMBL6174116 | 0.87 | IGF1R (0.33) | IGF1RLMNAPTGS1PTGS2 | |
| SCHEMBL6174557 | 0.86 | IGF1R (0.33) | IGF1RLMNAPTGS1PTGS2 | |
| SCHEMBL6171910 | 0.85 | NAMPT (0.47) | ELANENAMPT | |
| SCHEMBL6176021 | 0.85 | IGF1R (0.34) | IGF1RLMNAPTGS1PTGS2RXFP1 | |
| SCHEMBL6175990 | 0.83 | KIF11 (0.37) | IGF1RLMNANAMPTRXFP1 | |
| SCHEMBL6174450 | 0.83 | IGF1R (0.38) | IGF1RLMNANAMPTRXFP1 | |
| SCHEMBL6174089 | 0.83 | GAA (0.36) | IGF1RLMNANAMPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |